Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US

PURPOSE: We reported the first described post Ad26.COV2.S (Janssen, Johnson & Johnson) vaccine-induced immune thrombocytopenia (VITT) case outside US.  CASE DESCRIPTION: CA young woman without any medical history presented association of deep vein thrombosis and thrombocytopenia at day 10 after...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, Elsa V. C., Bouazza, Fatima-Zohra, Dauby, Nicolas, Mullier, François, d’Otreppe, Stéphanie, Jissendi Tchofo, Patrice, Bartiaux, Magali, Sirjacques, Camille, Roman, Alain, Hermans, Cédric, Cliquennois, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501343/
https://www.ncbi.nlm.nih.gov/pubmed/34626338
http://dx.doi.org/10.1007/s15010-021-01712-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501343/
https://www.ncbi.nlm.nih.gov/pubmed/34626338
http://dx.doi.org/10.1007/s15010-021-01712-8

Ejemplares similares